Small Cell Lung Cancer: New Hope, New Challenges
This commentary focuses on the exciting, unprecedented FDA accelerated approval of Tarlatamab in SCLC and highlights potential challenges that will be faced by Oncology community in integrating such I
Authors
- Parth Desai (ORCID: https://orcid.org/0000-0002-7715-4919)
- Anish Thomas (ORCID: https://orcid.org/0000-0003-3293-3115)
Institutions
- Fox Chase Cancer Center (US)
- National Institutes of Health (US)
- Temple University Hospital (US)
- National Cancer Institute (US)
Publication Details
- Journal
- JCO oncology advances.
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1200/oa.0000000000000001
- Citations
- 5
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.41